BFM
NVO

Boothbay Fund Management’s Novo Nordisk NVO Stock Holding History

Boothbay Fund Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.09M Buy
85,387
+57,267
+204% +$2.46M 0.05% 415
2026
Q1 		$1.03M Buy
28,120
+8,077
+40% +$383K 0.01% 930
2025
Q4 		$1.02M Buy
20,043
+8,064
+67% +$412K 0.02% 790
2025
Q3 		$665K Sell
11,979
-1,798
-13% -$105K 0.01% 1017
2025
Q2 		$951K Buy
+13,777
New +$937K 0.02% 696
2025
Q1 		– Sell
-22,833
Closed -$1.96M – 1666
2024
Q4 		$1.96M Sell
22,833
-43,439
-66% -$4.7M 0.05% 451
2024
Q3 		$7.89M Buy
66,272
+27,898
+73% +$3.72M 0.18% 139
2024
Q2 		$5.48M Sell
38,374
-18,589
-33% -$2.46M 0.13% 204
2024
Q1 		$7.31M Buy
56,963
+36,368
+177% +$4.33M 0.14% 124
2023
Q4 		$2.13M Buy
20,595
+13,820
+204% +$1.37M 0.05% 460
2023
Q3 		$616K Buy
6,775
+1,889
+39% +$166K 0.01% 950
2023
Q2 		$395K Sell
4,886
-2,186
-31% -$179K 0.01% 1197
2023
Q1 		$563K Sell
7,072
-23,484
-77% -$1.67M 0.01% 1206
2022
Q4 		$2.07M Sell
30,556
-71,210
-70% -$4.17M 0.05% 585
2022
Q3 		$5.07M Sell
101,766
-46,848
-32% -$2.51M 0.13% 188
2022
Q2 		$8.28M Buy
148,614
+21,284
+17% +$1.18M 0.22% 71
2022
Q1 		$7.07M Buy
127,330
+37,048
+41% +$1.9M 0.16% 120
2021
Q4 		$5.06M Buy
90,282
+45,338
+101% +$2.46M 0.12% 191
2021
Q3 		$2.16M Buy
+44,944
New +$2.17M 0.06% 418
2021
Q2 		– Sell
-6,464
Closed -$218K – 2032
2021
Q1 		$218K Buy
+6,464
New +$230K 0.01% 1328
2020
Q2 		– Sell
-8,728
Closed -$263K – 1071
2020
Q1 		$263K Buy
+8,728
New +$260K 0.02% 603

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boothbay Fund Management's NVO Position: Q2 2026 in Review

Boothbay Fund Management increased its Novo Nordisk (NVO) stake by 204% in Q2 2026, buying an estimated $2.46M and bringing the position to 85,387 shares worth $4.09M. The position accounts for 0.05% of the portfolio, ranked #415.

Boothbay Fund Management first reported a position in NVO in Q1 2020 and has held it in 21 quarters since. The position peaked at $8.28M in Q2 2022. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Boothbay Fund Management held 85,387 shares of Novo Nordisk worth $4.09M as of Q2 2026.
  • Boothbay Fund Management bought 57,267 Novo Nordisk shares in Q2 2026, an estimated $2.46M.
  • Novo Nordisk made up 0.05% of Boothbay Fund Management's portfolio in Q2 2026, its #415 holding.
  • Boothbay Fund Management first reported a position in Novo Nordisk in Q1 2020 and has held it in 21 quarters since.
  • Boothbay Fund Management's Novo Nordisk position peaked at $8.28M in Q2 2022.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.